Nöroimmünolojık Hastalıklarda Tanım ve Terminoloji

Peferon L, Kipp M, van der Valk P, van Noort JM, Amor S. Oligodendrocyte-microglia cross-talk in the central nervous system. Immunology 2014; 141:302-13.

E Nutma, H Willison, G Martino, S Amor. Neuroimmunology-the pat, present and future Clin Exp Immunol. 2019 Sep;197(3):278-293.

Demir BŞ, Azizoğlu ZB, Eken A. Nöroimmünolojik ve nörodejeneratif hastalıklarda immün sistem ve inflamatuar mekanizmalar. Canpolat M, editör. Nöroimmünoloji. 1. Baskı. Ankara: Türkiye Klinikleri; 2023. p.1-20.

Schluesener HJ, Sobel RA, Linington C, Weiner HL. A monoclonal antibody against a myelin oligodendrocyte glycoprotein induces relapses and demyelination in central nervous system autoimmune disease. J Immunol. 1987;139(12):4016-21.

C. L. de Mol, Y. Y. M. Wong, E. D. van Pelt, I. A. Ketelslegers, D. P. Bakker, M. Boon et al. Incidence and outcome of acquired demyelinating syndromes in Dutch children: update of a nationwide and prospective study. J Neurol. 2018;265(6):1310-9. doi: 10.1007/s00415-018-8835-6.

Alper G, Schor nF. Toward the definition of acute disseminated encephalitis of childhood. Curr Opin Pediatr. 2004;16(6):637-40. doi: 10.1097/01.mop.0000136120.83277.72.

Mader I, Wolff M, Niemann G, Küker W. Acute haemorrhagic encephalomyelitis (AHEM): MRI findings. Neuropediatrics. 2004;35(2):143-6. doi: 10.1055/s-2004-817906.

Huppke P, Rostasy K, Karenfort M, Huppke B, Seidl R, Leiz S, Reindl M, Gärtner J. Acute disseminated encephalomyelitis followed by recurrent or monophasic optic neuritis in pediatric patients. Mult Scler. 2013;19(7):941. Epub 2012 Nov 5.

Montalban X. 2024 Revisions of the McDonald Criteria. Presented at ECTRIMS Congress; September 18-20, 2024; Copenhagen, Denmark. Scientific Session 1: New diagnostic criteria.

Renoux C, Vukusic S, Mikaeloff Y, Edan G, Clanet M, Dubois B, Debouverie M, Brochet B, Lebrun-Frenay C, Pelletier J, Moreau T, Lubetzki C, Vermersch P, Roullet E, Magy L, Tardieu M, Suissa S, Confavreux C, Adult Neurology Departments KIDMUS Study Group Natural history of multiple sclerosis with childhood onset. N Engl J Med. 2007;356(25):2603.

Efendi H, Ünal A, Mavioğlu H, Altunrende B, İçen NK, Ergün U ve ark. Efendi H, Kuşcu DY, editörler. Multipl Skleroz Tani ve Tedavi Kılavuzu. İstanbul: Galenos Yayınevi; 2018. p.9-122.

Thompson AJ, Banwell BL, Barkhof F, Carroll WM, Coetzee T, Comi G. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol. 2018;17(2):162. Epub 2017 Dec 21.

Ulrike W Kaunzner Mais Al-Kawaz , Susan A Gauthier. Defining Disease Activity and Response to Therapy in MS. Curr Treat Options Neurol . 2017 May;19(5):20. doi: 10.1007/s11940-017-0454-5.

Miller D, Barkhof F, Montalban X, Thompson A, Filippi M. Clinically isolated syndromes suggestive of multiple sclerosis, part ı: natural history, pathogenesis, diagnosis, and prognosis. Lancet neurol. 2005;4(5):281-8. doi: 10.1016/s1474-4422(05)70071-5.

Siva A, Saip S, Altintas aA Jacob A, Keegan BM, Kantarci OH. Multiple sclerosis risk in radiologically uncovered asymptomatic possible inflammatory- demyelinating disease. mult scler. 2009;15(8):918-27. doi: 10.1177/1352458509106214

Okuda DT, Mowry EM, Beheshtian A, Waubant E, Baranzini SE, Goodin DS, et al. Incidental MRI anomalies suggestive of multiple sclerosis: the radiologically isolated syndrome. Neurology. 2009;72(9):800-5. doi: 10.1212/01.wnl.0000335764.14513.1a. Erratum in: Neurology. 2009;72(14):1284.

National multiple sclerosis society [ınternet]. © 2023 the national multiple sclerosis society. types of ms. available from: https://www.nationalmssoci- ety.org.

Freedman MS, Thompson EJ, Deisenhammer F, Giovannoni G, Grimsley G, Keir G, et al. Recommended standard of cerebrospinal fluid analysis in the di- agnosis of multiple sclerosis: a consensus statement. Arch Neurol. 2005;62(6):865-70. doi: 10.1001/archneur.62.6.865.

Andersson M, Alvarez-Cermeño J, Bernardi G, Cogato I, Fredman p, Frederiksen J, et al. Cerebrospinal fluid in the diagnosis of multiple sclerosis: a consensus report. J Neurol Neurosurg psychiatry. 1994;57(8):897-902. doi: 10.1136/jnnp.57.8.897. Erratum in: J Neurol Neurosurg psychiatry. 2011;82(7):826.

Deisenhammer F, Zetterberg H, Fitzner B, Zettl UK. The cerebrospinal fluid in multiple sclerosis. Front Immunol. 2019;10:726. doi: 10.3389/fimmu.2019.00726.

Gisslén M, price RW, Andreasson U, Norgren N, Nilsson S, Hagberg l, et al. plasma concentration of the neurofilament light protein (NFl) is a biomarker of CNS injury in HIv infection: a cross-sectional study. EBioMedicine. 2015;3:135- 40.

(Khalil M, Teunissen CE, Otto M, piehl F, Sormani Mp, Gattringer T, et al. Neurofilaments as biomarkers in neurological disorders. Nat Rev Neurol. 2018;14(10):577-89. doi: 10.1038/s41582-018-0058-z.)

Fang B, Mckeon A, Hinson sr, kryzer tj, Pittock sj, Aksamit Aj, et al. Autoimmune glial fibrillary acidic protein astrocytopathy: a novel meningoencephalomyelitis. jAMA neurol. 2016;73(11):1297-307. doi: 10.1001/jamaneurol.2016.2549.

Filippi M, Preziosa P, Banwell BL, Barkhof F, Ciccarelli O, De Stefano N, et al. Assessment of lesions on magnetic resonance imaging in multiple sclerosis: practical guidelines. Brain. 2019;142(7):1858-75.

Tatiana Abou Mrad, Kim Naja, Samia J. Khoury, Salem Hannoun. Central vein sign and paramagnetic rim sign: From radiologically isolated syndrome to multiple sclerosis. European journal of neurology. Eur J Neurol. 2023 Sep;30(9):2912-2918

Maggi P, Sati P, Nair G et al. Paramagnetic Rim Lesions Are Specific to Multple Sclerosis: An International Multicenter 3T MRI Study. Ann Neurol. 2020;88(5):1034-42.

Naismith RT, tUTLAM nt Xu J, Shepherd JB, Klawiter EC, Song SK, cROSS AH. Optical coherence tomography is less sensitive than visual evoked potentials in optic neuritis. Neurology. 2009;73(1):46.

James A Varley, Dimitrios Champsas, Timothy Prossor, , Omar Abdel-Mannan, Zhaleh Khaleeli. Validation of the 2023 International Diagnostic Criteria for MOGAD in a Selected Cohort of Adults and Children. Neurology. 2024 Jul;103(1):e209321.

Wingerchuk Dm, Banwell B, Bennett Jl, Cabre P, Carroll W, Chitnis t, et al; ınternational Panel for nmO Diagnosis. ınternational consensus diagnostic criteria for neuromyelitis optica spectrum disorders. neurology. 2015;85(2):177-89. doi: 10.1212/Wnl.0000000000001729.

Balcer LJ . Clinical practice. Optic neuritis. N Engl J Med. 2006;354(12):1273.

Lehman SS, Lavrich JB. Pediatric optic neuritis. Curr Opin Ophthalmol. 2018;29(5):419-22. doi: 10.1097/ICU.0000000000000509.

Wolf VL, Lupo pj, Lotze TE. pediatric acute transverse myelitis overview and differential diagnosis. j Child Neurol. 2012;27(11):1426-36. doi: 10.1177/0883073812452916.

Hajj-ali ra, Calabrese lH. Diagnosis and classification of central nervous system vasculitis. J autoimmun. 2014;48-49:149-52. doi: 10.1016/j.jaut.2014.01.007.

Lu JL, Sheikh KA, Wu HS, Zhang J, Jiang ZF, Cornblath DR, McKhann GM, Asbury AK , Griffin JW, Ho TW. Physiologic-pathologic correlation in Guillanne -Barresyndrome in children. Neurology. 2000;54(1):33.

McKhann GM, Cornblath DR, Griffin JW, Ho TW, Li CY, Jiang Z, Wu HS, Zhaori G, Liu Y, Jou LP. Acute motor axonal neuropathy: a frequent cause of acute flaccid paralysis in China. Ann Neurol. 1993;33(4):333.

Chiba A, Kusunoki S, Obata H, Machinami R, Kanazawa I. Serum anti-GQ1b IgG antibody is associated with ophthalmoplegia in Miller Fisher syndrome and Guillain-Barrésyndrome: clinical and immunohistochemical studies. Neurology. 1993;43(10):1911.

Lopez PHH, Báez BB. Gangliosides in axon stability and regeneration. Prog Mol Biol Transl Sci. 2018;156:383-412. doi: 10.1016/bs.pmbts.2018.03.001.

Ruts L, Van Koningsveld R, Van Doorn PA. Distinguishing acute-onset CIDP from Guillain-Barré syndrome with treatment related fluctuations. Neurology. 2005;65(1):138-40. doi: 10.1212/01.wnl.0000167549.09664.b8.

Brunschoten C, Jacobs BC, Van den Berg PYK, Cornblath DR, van Doorn PA. Progress in diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy. Lancet Neurol. 2019 ;18(8):784. Epub 2019 May 7.

Khanna L, Agrawal C, Gourie-Devi M, Bhandari AS. Seronegative autoimmune encephalitis: A Challenge for the Neurologist. Ann Indian Acad Neurol. 2022;25(2):280-3. doi: 10.4103/aian.aian_362_21. retraction in: ann ındian acad neurol. 2022;25(4):786.

Wright MA, Trandafir CC, Nelson GR, Hersh AO, Inman Cj, zielinski BA. Di- agnosis and management of suspected pediatric autoimmune encephalitis: a comprehensive, multidisciplinary approach and review of literature. j Child Neurol. 2022;37(4):303-13. doi: 10.1177/08830738211064673.

Dalmau J, Graus F. Antibody-Mediated Encephalitis. N Engl J Med. 2018 Mar 01;378(9):840-851.

Kothbauer-Margreiter I, Sturzenegger M, Komor J, Baumgarter R, Hess CW. Encephalopathy associated with hashimato thyroiditis: diagnosis and treatment. J Neurol. 1996;243(8):585.

Hung JY, Fan WX, Meng J, Cai CQ, Li D. ımmune characteristics of children with autoimmune encephalitis and the correlation with a short-term prog- nosis. ıtal J Pediatr. 2022;48(1):94. doi: 10.1186/s13052-022-01247-0.

Weinberg dH, Rizzo jF 3rd, Hayes mT, Kneeland md, Kelly jj jr. ocular myasthenia gravis: predictive value of single-fiber electromyography. muscle Nerve. 1999;22(9):1222-7. doi: 10.1002/(sici)1097-4598(199909)22:93.0.co;2-r.

Gilhus NE. Myastenia Gravis N Engl J Med. 2016;375(26):2570.

Benatar M. A systematic review of diagnostic studies in myasthenia gravis. Neuromuscul Disord. 2006;16(7):459-67. doi: 10.1016/j.nmd.2006.05.006. ///. Gilhus NE, verschuuren JJ. Myasthenia gravis: subgroup classification and therapeutic strategies. lancet Neurol. 2015;14(10):1023-36. doi: 10.1016/S1474-4422(15)00145-3

Wirtz pW, Smallegange TM, Wintzen AR, verschuuren JJ. Differences in clinical features between the lambert-Eaton myasthenic syndrome with and without cancer: an analysis of 227 published cases. Clin Neurol Neurosurg. 2002;104(4):359-63. doi: 10.1016/s0303-8467(02)00054-9.)

Quek AM, Britton JW, McKeon A, So E, Lennon VA, Shin C, et al. Autoimmune epilepsy: clinical characteristics and response to immunotherapy. Arch Neu- rol. 2012;69(5):582-93. doi: 10.1001/archneurol.2011.2985.

Khalil S Husari, Divyanshu Dubey. Autoimmune Epilepsy. Neurotherapeutics. 2019 Jun 25;16(3):685–702.

Varadkar S, Bien CG, Kruse CA, Jensen FE, Bauer J, Pardo CA, et al. Rasmussen’s encephalitis: Clinical features, pathobiology, and treatment advances. Lancet Neurol. 2014;13(2):195-205. doi: 10.1016/S1474-4422(13)70260-6

JJ Westfall, WN Schwind, S Sran, JB Navarro, J Leonard, JA Pindrik, et al. Molecular and spatial heterogeneity of microglia in Rasmussen encephalitis Acta Neuropathol Commun, 10 (2022), 10.1186/S40478-022-01472-

Dalmau J, Gultekin HS, Posner JB, Paraneoplastic neurologic syndromes; pathogenesis and physiopathology. Brain Pathol. 1999;9(2):275.)

Gök V, Per H. Opsoclonus myoclonus ataxia syndrome paraneoplastic syndromes A. Ünal E, editör. Focusing on Pediatric ımmunology & Neurology. 1. Baskı. Ankara: Nobel Tıp Kitabevleri; 2021. p.276-81.

Shan F, long Y, qiu W. Autoimmune glial fibrillary acidic protein astrocy- topathy: a review of the literature. Front Immunol. 2018;9:2802. doi: 10.3389/fimmu.2018.02802.

Dale RC, Brilot F. Autoimmune basal ganglia disorders. J Child Neurol. 2012;27(11):1470-81.

Şimşek E, Yılmaz S. Otoimmün bazal ganglia hastalıkları. Canpolat M, editör. Nöroimmü- noloji. 1. Baskı. Ankara: Türkiye Klinikleri; 2023. p.150-8.

Mitoma H, Adhikari K, Aeschlimann D, Chattopadhyay P, Hadjivassiliou M, Hampe CS, et al. Consensus paper: neuroimmune mechanisms of cerebel- lar ataxias. Cerebellum. 2016;15(2):213-32. doi: 10.1007/s12311-015-0664- x.

Connoly AM, Dodson WE, Prensky AL, Rust RS. Course and outcome of acute cerebellar ataxia. Ann Neurol. 1994;35(6):673.)

Takashi Shiihara, Mitsuhiro Kato, Akihiro Konno, Yukitoshi Takahashi, Kiyoshi Hayasaka. Acute serebellar ataxia and consecutive cerebellitis produced by glutamate receptor delta2 autoantobody. Brain Dev. 2007 May;29(4):254-6.